$CTEV

Misencik Tiffani sold $355K of CTEV

Misencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares of Claritev Corp (CTEV) at $40.07 ($0.35M total) on 2026-08-14.

Original reporting
SEC EDGAR · Misencik Tiffani
Published Aug 18, 2026, 9:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CTEV
Neutral
high confidence
Mentioned
$CTEV
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTEVNeutralLow
01

Why it matters

The newest fact is the reported open-market sale size, price, and post-transaction holdings by an SVP, which may slightly influence sentiment but does not introduce new company-specific fundamentals.

02

Market read

Traders may note the insider sale for sentiment, but there is no accompanying catalyst such as earnings, guidance, or regulatory action.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but the article still lacks context on whether the sale was planned for personal reasons.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-18, transaction dated 2026-08-14

Background

The article is an SEC Form 4 insider transaction disclosure for Claritev Corp (CTEV).

Company-level read

Ticker impact

$CTEVNeutralHigh confidence
Context

Claritev Corp (CTEV) disclosed an insider open-market sale by SVP Chief Growth Officer Misencik Tiffani of 8,850 shares at $40.0670.

Expected impact

Likely minimal near-term impact; any effect is more about signaling than fundamentals.

Evidence & confidence

The filing is an open-market sale, not a buy, and the text provides no new operational, financial, or regulatory development for CTEV.

Market effects

No sector read-through is provided; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Insider selling can be driven by diversification or liquidity needs, so it may not reflect bearish expectations.

Key entities

  • Claritev Corp

    Subject of the Form 4 insider transaction disclosure.

  • Misencik Tiffani

    SVP, Chief Growth Officer who sold 8,850 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTEVMedAI 8/10

Claritev Q2 Earnings Call Highlights

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

$CTEVMed

Claritev Corp (CTEV): Results of Operations and Financial Condition

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202